Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

Mutations of the BRAF gene in human cancer

Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674

In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2

Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,336

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

Kimura, E. T., Nikiforova, M. N., Zhu, Z., Knauf, J. A., Nikiforov, Y. E., & Fagin, J. A. (2003) · PubMed · Cited by 1,510

BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030838 · Cited by 1,036

New Human Tumor Cell Lines

Fogh, J., & Trempe, G. (1975) · Springer eBooks · doi:10.1007/978-1-4757-1647-4_5 · Cited by 1,034

Molecular characterization of human prostate carcinoma cell lines

van Bokhoven, A., Varella‐Garcia, M., Korch, C. T., Johannes, W. U., Smith, E. E., Miller, H. L., Nordeen, S. K., Miller, G. J., & Lucia, M. S. (2003) · The Prostate · doi:10.1002/pros.10290 · Cited by 635

Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers

Namba, H., Nakashima, M., Hayashi, T., Hayashida, N., Maeda, S., Rogounovitch, T., Ohtsuru, A., Saenko, V., Kanematsu, T., & Yamashita, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030305 · Cited by 532

Short tandem repeat profiling provides an international reference standard for human cell lines

Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478

Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA , and AKT1

Ricarte‐Filho, J. C., Ryder, M. M., Chitale, D. A., Rivera, M., Heguy, A., Ladanyi, M., Janakiraman, M., Solit, D. B., Knauf, J. A., Tuttle, R. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0727 · Cited by 532

Check your cultures! A list of cross‐contaminated or misidentified cell lines

Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520

Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies

Smallridge, R. C., & Copland, J. A. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.03.013 · Cited by 480

Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies

Smallridge, R. C., Marlow, L. A., & Copland, J. A. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0154 · Cited by 396

Relief of Feedback Inhibition of HER3 Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in BRAF -Mutant Thyroid Carcinomas

Montero-Conde, C., Ruiz-Llorente, S., Dominguez, J. M., Knauf, J. A., Viale, A., Sherman, E. J., Ryder, M., Ghossein, R. A., Rosen, N., & Fagin, J. A. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0531 · Cited by 382

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing

Kunstman, J. W., Juhlin, C. C., Goh, G., Brown, T. C., Stenman, A., Healy, J. M., Rubinstein, J. C., Choi, M., Kiss, N. B., Nelson-Williams, C. J., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu749 · Cited by 366

Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer

Janakiraman, M., Vakiani, E., Zeng, Z., Pratilas, C. A., Taylor, B. S., Chitale, D., Halilovic, E., Wilson, M., Huberman, K., Ricarte Filho, J. C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0192 · Cited by 290

Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites

Zhao, M., Sano, D., Pickering, C. R., Jasser, S. A., Henderson, Y. C., Clayman, G. L., Sturgis, E. M., Ow, T. J., Lotan, R., Carey, T. E., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0690 · Cited by 282

Cell line misidentification: the beginning of the end

American Type Culture Collection Standards Development Organization Workgroup ASN-0002 (2010) · Nature Reviews Cancer · doi:10.1038/nrc2852 · Cited by 266

ETV6‐NTRK3 is a common chromosomal rearrangement in radiation‐associated thyroid cancer

Leeman‐Neill, R. J., Kelly, L. M., Liu, P., Brenner, A. V., Little, M. P., Ti, B., Evdokimova, V. N., HATCH, M. C., Zurnadzhy, L. Y., Nikiforova, M. N., et al. (2013) · Cancer · doi:10.1002/cncr.28484 · Cited by 257

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

Korch, C. T., Spillman, M. A., Jackson, T. A., Jacobsen, B. M., Murphy, S. K., Lessey, B. A., Jordan, V. C., & Bradford, A. P. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.06.017 · Cited by 249

Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research

Gazdar, A. F., Girard, L., Lockwood, W. W., Lam, W. L., & Minna, J. D. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq279 · Cited by 240

NADPH oxidases and cancer

Roy, K., Wu, Y., Meitzler, J. L., Juhasz, A. N., Liu, H., Jiang, G., Lu, J., Antony, S., & Doroshow, J. H. (2015) · Clinical Science · doi:10.1042/cs20140542 · Cited by 230

Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?

van Staveren, W. C. G., Solís, D. Y. W., Hébrant, A., Detours, V., Dumont, J. E., & Maenhaut, C. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.12.004 · Cited by 231

Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid

Savvides, P. S., Nagaiah, G., Lavertu, P., Fu, P., Wright, J. J., Chapman, R., Wasman, J. K., Dowlati, A., & Remick, S. C. (2012) · Thyroid · doi:10.1089/thy.2012.0103 · Cited by 219

NADPH Oxidases: A Perspective on Reactive Oxygen Species Production in Tumor Biology

Meitzler, J. L., Antony, S., Wu, Y., Juhasz, A. N., Liu, H., Jiang, G., Lu, J., Roy, K., & Doroshow, J. H. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5603 · Cited by 213

The sodium iodide symporter (NIS): Regulation and approaches to targeting for cancer therapeutics

Kogai, T., & Brent, G. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.06.007 · Cited by 196

Anaplastic Thyroid Cancers Harbor Novel Oncogenic Mutations of the ALK Gene

Murugan, A. K., & Xing, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4041 · Cited by 200

Match criteria for human cell line authentication: Where do we draw the line?

Capes‐Davis, A., Reid, Y. A., Kline, M. C., Storts, D. R., Strauss, E., Dirks, W. G., Drexler, H. G., MacLeod, R. A. F., Sykes, G., Kohara, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27931 · Cited by 180

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

Landa, I., Pozdeyev, N. V., Korch, C. T., Marlow, L. A., Smallridge, R. C., Copland, J. A., Henderson, Y. C., Lai, S. Y., Clayman, G. L., Onoda, N., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2953 · Cited by 188

B-Raf V600E and thrombospondin-1 promote thyroid cancer progression

Nucera, C., Porrello, A., Antonello, Z. A., Mekel, M., Nehs, M. A., Giordano, T. J., Gerald, D., Benjamin, L. E., Priolo, C., Puxeddu, E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004934107 · Cited by 169

The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors

Landa, I., Ruiz‐Llorente, S., Montero‐Conde, C., Inglada‐Pérez, L., Schiavi, F., Leskelä, S., Pita, G., Milne, R. L., Maravall, J., Ramos, I., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000637 · Cited by 168

Thyroid cancer cell lines: an overview

Saiselet, M., Floor, S. L., Tarabichi, M., Dom, G., Hébrant, A., van Staveren, W. C. G., & Maenhaut, C. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00133 · Cited by 156

MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro

Angell, T. E., Lechner, M. G., Jang, J. K., LoPresti, J. S., & Epstein, A. L. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0879 · Cited by 153

Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Gazdar, A. F., Gao, B., & Minna, J. D. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.12.005 · Cited by 157

Local Anesthetics Induce Apoptosis in Human Thyroid Cancer Cells through the Mitogen-Activated Protein Kinase Pathway

Chang, Y., Hsu, Y., Liu, C., Huang, S., Hu, M., & Cheng, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089563 · Cited by 145

Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity

Tanaka, N., Osman, A. A., Takahashi, Y., Lindemann, A., Patel, A. A., Zhao, M., Takahashi, H., & Myers, J. N. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.10.018 · Cited by 144

Cytotoxic Chemotherapy for Differentiated Thyroid Carcinoma

Sherman, S. I. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.03.014 · Cited by 142

Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells

Sponziello, M., Rosignolo, F., Celano, M., Maggisano, V., Pecce, V., Rose, R. F. D., Lombardo, G. E., Durante, C., Filetti, S., Damante, G., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.05.007 · Cited by 142

NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition

García-Rendueles, M. E. R., Ricarte‐Filho, J. C., Untch, B. R., Landa, I., Knauf, J. A., Voza, F. A., Smith, V. E., Ganly, I., Taylor, B. S., Persaud, Y., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0330 · Cited by 139

Reproducibility: changing the policies and culture of cell line authentication

Freedman, L. P., Gibson, M. C., Ethier, S. P., Soule, H. R., Neve, R. M., & Reid, Y. A. (2015) · Nature Methods · doi:10.1038/nmeth.3403 · Cited by 136

Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets

Knauf, J. A., & Fagin, J. A. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.013 · Cited by 131

Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling Pathways

Hou, P., Bojdani, E., & Xing, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1888 · Cited by 128

Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics In Vitro and In Vivo , Independent of p53 Functionality

Linden, A. A. V., Baturin, D., Ford, J. B., Fosmire, S. P., Gardner, L. A., Korch, C. T., Reigan, P., & Porter, C. C. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0424 · Cited by 127

Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages

Arts, R. J. W., Plantinga, T. S., Tuit, S., Ulas, T., Heinhuis, B., Tesselaar, M. H., Sloot, Y. J. E., Adema, G. J., Joosten, L. A. B., Smit, J. W. A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1229725 · Cited by 118

Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues

Barallon, R., Bauer, S. R., Butler, J., Capes-Davis, A., Dirks, W. G., Elmore, E., Furtado, M., Kline, M. C., Kohara, A., Los, G. V., et al. (2010) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-010-9333-z · Cited by 116

Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cells

Du, Z., Zhang, H.-Y., Meng, X., Guan, Y., & Wang, H.-Q. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-56 · Cited by 111

Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis

Chan, C. M., Jing, X., Pike, L. A., Zhou, Q., Lim, D., Sams, S. B., Lund, G. S., Sharma, V., Haugen, B. R., & Schweppe, R. E. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3359 · Cited by 113

Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth

Yu, X.-M., Jaskula‐Sztul, R., Ahmed, K., Harrison, A. D., Kunnimalaiyaan, M., & Chen, H. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0841 · Cited by 107

Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2

Phuchareon, J., Ohta, Y., Woo, J. M., Eisele, D. W., & Tetsu, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006040 · Cited by 105

Cell line cross‐contamination initiative: An interactive reference database of STR profiles covering common cancer cell lines

Dirks, W. G., MacLeod, R. A. F., Nakamura, Y., Kohara, A., Reid, Y., Milch, H., Drexler, H. G., & Mizusawa, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.24999 · Cited by 104

Expression of hypoxia-inducible factor 1α in thyroid carcinomas

Burrows, N., Resch, J., Cowen, R. L., von Wasielewski, R., Hoang‐Vu, C., West, C., Williams, K. J., & Brabant, G. E. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0251 · Cited by 107

Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer

Morrison, J. A., Pike, L. A., Sams, S. B., Sharma, V., Zhou, Q., Severson, J. J., Tan, A. C., Wood, W. M., & Haugen, B. R. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-62 · Cited by 102

miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma

Minna, E., Romeo, P., Dugo, M., Cecco, L. D., Todoerti, K., Pilotti, S., Perrone, F., Seregni, E. C., Agnelli, L., Neri, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7262 · Cited by 102

Redifferentiation of radioiodine-refractory thyroid cancers

Buffet, C., Wassermann, J., Hecht, F., Leenhardt, L., Dupuy, C., Groussin, L., & Lussey‐Lepoutre, C. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0491 · Cited by 101

In Vitro Identification and Characterization of CD133pos Cancer Stem-Like Cells in Anaplastic Thyroid Carcinoma Cell Lines

Zito, G., Richiusa, P., Bommarito, A., Carissimi, E., Russo, L., Coppola, A., Zerilli, M., Rodolico, V., Criscimanna, A., Amato, M. C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003544 · Cited by 98

Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors inBRAFMutant Thyroid Carcinoma Cells

Salerno, P., Falco, V. D., Tamburrino, A., Nappi, T. C., Vecchio, G., Schweppe, R. E., Bollag, G. E., Santoro, M. M., & Salvatore, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0373 · Cited by 98

Downregulation of Rap1GAP through Epigenetic Silencing and Loss of Heterozygosity Promotes Invasion and Progression of Thyroid Tumors

Zuo, H., Gandhi, M., Edreira, M. M., Hochbaum, D. R., Nimgaonkar, V. L., Zhang, P., DiPaola, J. E., Evdokimova, V. N., Altschuler, D. L., & Nikiforov, Y. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2812 · Cited by 96

Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo

Yu, X., Phan, T., Patel, P. N., Jaskula‐Sztul, R., & Chen, H. (2012) · Cancer · doi:10.1002/cncr.27742 · Cited by 93

Targeting BRAFV600E with PLX4720 Displays Potent Antimigratory and Anti-invasive Activity in Preclinical Models of Human Thyroid Cancer

Nucera, C., Nehs, M. A., Nagarkatti, S. S., Sadow, P. M., Mekel, M., Fischer, A. H., Lin, P., Bollag, G. E., Lawler, J., Hodin, R. A., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0317 · Cited by 91

Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and Mammalian Target of Rapamycin

Liu, D., Hou, P., Liu, Z., Wu, G., & Xing, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1077 · Cited by 88

TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells

Anania, M. C., Sensi, M., Radaelli, E., Miranda, C., Vizioli, M. G., Pagliardini, S., Favini, E., Cleris, L., Supino, R., Formelli, F., et al. (2011) · Oncogene · doi:10.1038/onc.2011.18 · Cited by 89

The β-Catenin Axis Integrates Multiple Signals Downstream from RET/Papillary Thyroid Carcinoma Leading to Cell Proliferation

Castellone, M. D., Falco, V. D., Rao, D. M., Bellelli, R., Muthu, M., Basolo, F., Fusco, A., Gutkind, J. S., & Santoro, M. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1982 · Cited by 87

Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells

Prazeres, H., Torres, J., Rodrigues, F., Pinto, M. T., Pastoriza, M. C., Gomes, D., Cameselle‐Teijeiro, J., Vidal, A., Martins, T., Sobrinho-Simões, M. A., et al. (2010) · Oncogene · doi:10.1038/onc.2010.512 · Cited by 87

SRGAP1 Is a Candidate Gene for Papillary Thyroid Carcinoma Susceptibility

He, H., Bronisz, A., Liyanarachchi, S., Nagy, R. S., Li, W., Huang, Y., Akagi, K., Saji, M., Kula, D., Wójcicka, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3823 · Cited by 86

Thyroid cancer stem cells

Lin, R.-Y. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.127 · Cited by 86

Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas

Kondo, T., Nakazawa, T., Ma, D., Niu, D., Mochizuki, K., Kawasaki, T., Nakamura, N., Yamane, T., Kobayashi, M., & Katoh, R. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.50 · Cited by 86

The Sonic Hedgehog Signaling Pathway Maintains the Cancer Stem Cell Self-Renewal of Anaplastic Thyroid Cancer by Inducing Snail Expression

Heiden, K. B., Williamson, A. J., Doscas, M. E., Ye, J., Wang, Y., Liu, D., Xing, M., Prinz, R. A., & Xu, X. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1844 · Cited by 86

Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells

Bulotta, S., Corradino, R., Celano, M., Maiuolo, J., D’Agostino, M. N., Oliverio, M., Procopio, A., Filetti, S., & Russo, D. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0241 · Cited by 85

Erratum: Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells

Prazeres, H., Torres, J., Rodrigues, F., Pinto, M. T., Pastoriza, M. C., Gomes, D., Cameselle‐Teijeiro, J., Vidal, A., Martins, T., Sobrinho-Simões, M. A., et al. (2016) · Oncogene · doi:10.1038/onc.2016.143 · Cited by 86

Induction of an Inflammatory Loop by Interleukin-1β and Tumor Necrosis Factor-α Involves NF-kB and STAT-1 in Differentiated Human Neuroprogenitor Cells

Pugazhenthi, S., Zhang, Y., Bouchard, R. J., & Mahaffey, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069585 · Cited by 87

Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment

Moretti, S., Menicali, E., Voce, P., Morelli, S., Cantarelli, S., Sponziello, M., Colella, R., Fallarino, F., Orabona, C., Alunno, A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3351 · Cited by 83

Novel Variant of Thyroglobulin Promoter Triggers Thyroid Autoimmunity through an Epigenetic Interferon α-modulated Mechanism

Stefan, M., Jacobson, E. M., Huber, A. K., Greenberg, D. A., Li, C. W., Skrabanek, L., Conception, E., Fadlalla, M., Ho, K., & Tomer, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.247510 · Cited by 85

CD44 Proteolysis Increases CREB Phosphorylation and Sustains Proliferation of Thyroid Cancer Cells

Falco, V. D., Tamburrino, A., Ventre, S., Castellone, M. D., Malek, M., Manié, S. N., & Santoro, M. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3320 · Cited by 81

A Novel Orthotopic Mouse Model of Human Anaplastic Thyroid Carcinoma

Nucera, C., Nehs, M. A., Mekel, M., Zhang, X., Hodin, R. A., Lawler, J., Nosé, V., & Parangi, S. (2009) · Thyroid · doi:10.1089/thy.2009.0055 · Cited by 80

FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma

Nucera, C., Eeckhoute, J., Finn, S. P., Carroll, J. S., Ligon, A. H., Priolo, C., Fadda, G., Toner, M. E., Sheils, O. M., Attard, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3155 · Cited by 81

MEK Inhibitor PD0325901 Significantly Reduces the Growth of Papillary Thyroid Carcinoma Cells In vitro and In vivo

Henderson, Y. C., Chen, Y., Frederick, M. J., Lai, S. Y., & Clayman, G. L. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0062 · Cited by 80

DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers

Buffet, C., Perlemoine, K., Bricaire, L., Dumont, F., Baudry, C., Tissier, F., Bertherat, J. Y., Cochand‐Priollet, B., Raffin‐Sanson, M., Cormier, F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184861 · Cited by 79

Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling

Nelson-Taylor, S. K., Le, A. T., Yoo, M., Schubert, L., Mishall, K. M., Doak, A. E., Varella‐Garcia, M., Tan, A. C., & Doebele, R. C. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0008 · Cited by 79

Laminin-5γ-2 (LAMC2) Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Progression, Migration, and Invasion by Modulating Signaling of EGFR

Garg, M., Kanojia, D., Okamoto, R., Jain, S., Madan, V., Chien, W., Kumar, A. S., Ding, L., Xuan, M., SAID, J. W., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2994 · Cited by 78

LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer

Shi, L., Duan, R., Sun, Z., Jia, Q., Wu, W., Wang, F., Liu, J., Zhang, H., & Xue, X. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01157-6 · Cited by 80

Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

Gule, M. K., Chen, Y., Sano, D., Frederick, M. J., Zhou, G., Zhao, M., Milas, Z. L., Galer, C. E., Henderson, Y. C., Jasser, S. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2762 · Cited by 77

Analysis of Exosome Release as a Cellular Response to MAPK Pathway Inhibition

Agarwal, K., Saji, M., Lazaroff, S. M., Palmer, A. F., Ringel, M. D., & Paulaitis, M. E. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b00095 · Cited by 78

Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer

Jin, N. Y., Jiang, T., Rosen, D. M., Nelkin, B. D., & Ball, D. W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0662 · Cited by 78

Potential Utility and Limitations of Thyroid Cancer Cell Lines as Models for Studying Thyroid Cancer

Pilli, T., Prasad, K. V. S., Jayarama, S., Pacini, F., & Prabhakar, B. S. (2009) · Thyroid · doi:10.1089/thy.2009.0195 · Cited by 76

Targeted therapy of thyroid cancer

Sherman, S. I. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.003 · Cited by 77

Hesperetin Activates the Notch1 Signaling Cascade, Causes Apoptosis, and Induces Cellular Differentiation in Anaplastic Thyroid Cancer

Patel, P. N., Yu, X.-M., Jaskula‐Sztul, R., & Chen, H. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3459-7 · Cited by 75

Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model

Danysh, B. P., Rieger, E. Y., Sinha, D. K., Evers, C., Cote, G. J., Cabanillas, M. E., & Hofmann, M.-C. C. (2016) · Oncotarget · doi:10.18632/oncotarget.9023 · Cited by 74

Striving for transparent and credible research: practical guidelines for behavioral ecologists

Ihle, M., Winney, I. S., Krystalli, A., & Croucher, M. (2017) · Behavioral Ecology · doi:10.1093/beheco/arx003 · Cited by 72

Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways

Lee, J.-J. (2011) · Oncology Reports · doi:10.3892/or.2011.1388 · Cited by 73

Dysregulation of secretion of CXC α-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-γ agonists

Antonelli, A., Ferrari, S. M., Fallahi, P., Frascerra, S., Piaggi, S., Gelmini, S., Lupi, C., Minuto, M. N., Berti, P., Benvenga, S., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0337 · Cited by 73

Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target

Marlow, L. A., D'Innocenzi, J., Zhang, Y., Rohl, S. D., Cooper, S. J., Sebo, T., Grant, C. S., McIver, B., Kasperbauer, J. L., Wadsworth, J. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1421 · Cited by 72

The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy

Kasaian, K., Wiseman, S. M., WALKER, B. A. M., Schein, J. E., Zhao, Y., Hirst, M., Moore, R. A., Mungall, A. J. J., Marra, M. A., & Jones, S. J. M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1955-9 · Cited by 72

Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression

Xu, X., Rao, G., Groh, V., Spies, T. A., Gattuso, P., Kaufman, H. L., PLATE, J. M. D., & Prinz, R. A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-194 · Cited by 71

BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy

Bommarito, A., Richiusa, P., Carissimi, E., Pizzolanti, G., Rodolico, V., Zito, G., Criscimanna, A., Di Blasi, F., Pitrone, M., Zerilli, M., et al. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0076 · Cited by 70

The Oleaceae family: A source of secoiridoids with multiple biological activities

Huang, Y., Oppong, M. B., Guo, Y., Wang, L., Fang, S., Deng, Y., & Gao, X. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.04.010 · Cited by 70

Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics

Rabold, K., Aschenbrenner, A. C., Thiele, C., Boahen, C. K., Schiltmans, A., Smit, J. W. A., Schultze, J. L., Netea, M. G., Adema, G. J., & Netea-Maier, R. T. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000638 · Cited by 73

Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib

Wang, W., Kang, H. H., Zhao, Y., Min, I. M., Wyrwas, B., Moore, M. D., Teng, L., Zarnegar, R., Jiang, X., & Fahey, T. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1999 · Cited by 71

Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer

Isham, C. R., Bossou, A. R., Negron, V. C., Fisher, K. E., Kumar, R., Marlow, L. A., Lingle, W. L., Smallridge, R. C., Sherman, E. J., Suman, V. J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004358 · Cited by 69

High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells

Toteda, G., Lupinacci, S., Vizza, D., Bonofiglio, R., Perri, E., Bonofiglio, M., Lofaro, D., Russa, A. L., Leone, F., Gigliotti, P., et al. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0537-2 · Cited by 69

CD133+ Anaplastic Thyroid Cancer Cells Initiate Tumors in Immunodeficient Mice and Are Regulated by Thyrotropin

Friedman, S., Lü, M., Schultz, A., Thomas, D., & Lin, R.-Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005395 · Cited by 69

Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Marlow, L. A., Reynolds, L. A., Cleland, A. S., Cooper, S. J., Gumz, M. L., Kurakata, S., Fujiwara, K., Zhang, Y., Sebo, T., Grant, C. S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3718 · Cited by 69

Antiproliferation and Redifferentiation in Thyroid Cancer Cell Lines by Polyphenol Phytochemicals

Kang, H. J., Youn, Y., Hong, M.-K., & Kim, L. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.7.893 · Cited by 69

Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib

Ooi, M. G. M., Hayden, P. J., Kotoula, V., McMillin, D. W., Charalambous, E., Daskalaki, E., Raje, N. S., Munshi, N. C., Chauhan, D., Hideshima, T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1071 · Cited by 69

Estrogen Receptor α Induces Prosurvival Autophagy in Papillary Thyroid Cancer via Stimulating Reactive Oxygen Species and Extracellular Signal Regulated Kinases

Fan, D., Liu, S. Y., van Hasselt, C. A., Vlantis, A. C., Ng, E. K., Zhang, H., Dong, Y., Ng, S. K., Chu, R., Chan, A. B. W., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3257 · Cited by 71

The oncolytic virusdl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma

Passaro, C., Borriello, F., Vastolo, V., Somma, S. D., Scamardella, E., Gigantino, V., Franco, R., Marone, G., & Portella, G. (2015) · Oncotarget · doi:10.18632/oncotarget.6430 · Cited by 68

Multiple Pluripotent Stem Cell Markers in Human Anaplastic Thyroid Cancer: The Putative Upstream Role of SOX2

Carina, V., Zito, G., Pizzolanti, G., Richiusa, P., Criscimanna, A., Rodolico, V., Tomasello, L., Pitrone, M., Arancio, W., & Giordano, C. S. D. S. (2013) · Thyroid · doi:10.1089/thy.2012.0372 · Cited by 67

Selective multiplexed enrichment for the detection and quantitation of low-fraction DNA variants via low-depth sequencing

Song, P., Chen, S. X., Yan, Y. H., Pinto, A., Cheng, L. Y., Dai, P., Patel, A. A., & Zhang, D. Y. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00713-0 · Cited by 68

Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancer

Schweppe, R. E., Kerege, A. A., French, J. D., Sharma, V., Grzywa, R. L., & Haugen, B. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2511 · Cited by 66

The Nuclear Factor Kappa-B Signaling Pathway as a Therapeutic Target Against Thyroid Cancers

Li, X., Abdel‐Mageed, A. B., Mondal, D., & Kandil, E. H. (2012) · Thyroid · doi:10.1089/thy.2012.0237 · Cited by 67

Thyroid Cancer Cell Line Misidentification: An Update

Schweppe, R. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4182 · Cited by 11

The Author Response Antiproliferation and Redifferentiation in Thyroid Cancer Cell

Phytochemicals, L. P., Kang, H. J., Youn, Y.-K., Hong, M.-K., & Kim, L. S. (2013)

The Author Response: Antiproliferation and Redifferentiation in Thyroid Cancer Cell Line by Polyphenol Phytochemicals

Kang, H. J., Youn, Y., Hong, M.-K., & Kim, L. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.10.1398 · Cited by 2

Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts

Marlow, L. A., Rohl, S. D., Miller, J. L., Knauf, J. A., Fagin, J. A., Ryder, M. M., Milosevic, D., Netzel, B. C., Grebe, S. K. G., Reddi, H. V., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01845 · Cited by 19

Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples

Ribeiro, F. R., Meireles, A. M., Rocha, A. S., & Teixeira, M. R. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-371 · Cited by 41